{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:01:00Z","timestamp":1770058860608,"version":"3.49.0"},"reference-count":28,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T00:00:00Z","timestamp":1658016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Cytokine storm is a condition in which the immune system produces an excessive number of inflammatory signals, which can result in organ failure and death. It is also known as cytokine release syndrome, CRS, or simply cytokine storm, and it has received a lot of attention recently because of the COVID-19 pandemic. It appears to be one of the reasons why some people experience life-threatening symptoms from COVID-19, a medical condition induced by SARS-CoV-2 infection. In situations where natural substances can be exploited as therapeutics to reduce cytokine storm, the drug development process has come to the rescue. In the present study, we tested the potentiality of Andrographolide, labdane diterpenoid targeting several key cytokines that are secreted as a result of cytokine storm. We used molecular docking analyses, molecular dynamics simulations, and pharmacokinetic properties to test the stability of the complexes. The compound\u2019s binding energy with some cytokines was over \u22126.5 Kcal\/mol. Furthermore, a post-molecular dynamics (MD) study revealed that Andrographolide was extremely stable with these cytokines. The compound\u2019s pharmacokinetic measurements demonstrated excellent properties in terms of adsorption, distribution, metabolism, and excretion. Our research revealed that this compound may be effective in lowering cytokine storm and treating severe symptoms.<\/jats:p>","DOI":"10.3390\/molecules27144555","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T01:53:22Z","timestamp":1658109202000},"page":"4555","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A New Investigation into the Molecular Mechanism of Andrographolide towards Reducing Cytokine Storm"],"prefix":"10.3390","volume":"27","author":[{"given":"Abdulaziz","family":"Alzahrani","sequence":"first","affiliation":[{"name":"Pharmaceuticals Chemistry Department, Faculty of Clinical Pharmacy, Al Baha University, Al Baha 65779, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, Inflammation and Pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"ref_2","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- A n update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-020-0191-1","article-title":"Immune response in COVID-19: Addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2","volume":"5","author":"Catanzaro","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tang, D., Comish, P., and Kang, R. (2020). The hallmarks of COVID-19 disease. PLOS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008536"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa1406430","article-title":"Ivabradine in stable coronary artery disease without clinical heart failure","volume":"371","author":"Fox","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1053\/j.gastro.2021.02.040","article-title":"The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338\u20133p Are Downregulated in Irritable Bowel Syndrome and Are Associated with Barrier Function and MAPK Signaling","volume":"160","author":"Rankin","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"D12","DOI":"10.1093\/nar\/gkw1071","article-title":"Database Resources of the National Center for Biotechnology Information","volume":"45","author":"Agarwala","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_8","first-page":"27","article-title":"Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation","volume":"6","author":"Amroyan","year":"1999","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.intimp.2008.12.002","article-title":"Ezeamuzie, In Vitro and in vivo anti-inflammatory effects of andrographolide","volume":"9","author":"Canatan","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.106.103259","article-title":"Inhibition of nuclear factor-\u03baB enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis","volume":"318","author":"Iruretagoyena","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.2174\/0929867324666171107101035","article-title":"The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization","volume":"26","author":"Bruno","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.bjp.0707305","article-title":"In Silico pharmacology for drug discovery: Methods for virtual ligand screening and profiling","volume":"152","author":"Ekins","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"104851","DOI":"10.1016\/j.compbiomed.2021.104851","article-title":"In Silico methods and tools for drug discovery","volume":"137","author":"Shaker","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.2174\/092986712801661112","article-title":"Structure and Ligand Based Drug Design Strategies in the Development of Novel 5-LOX Inhibitors","volume":"19","author":"Aparoy","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_15","unstructured":"(2022, June 28). Profile of Cytokines. Available online: https:\/\/www.thermofisher.com\/sa\/en\/home\/life-science\/antibodies\/immunoassays\/procartaplex-assays-luminex\/procartaplex-immunoassays\/cytokine-panels.html?ef_id."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1021\/acs.jchemed.5b00404","article-title":"RCSB Protein Data Bank: A Resource for Chemical, Biochemical, and Structural Explorations of Large and Small Biomolecules","volume":"93","author":"Zardecki","year":"2016","journal-title":"J. Chem. Educ."},{"key":"ref_17","first-page":"262","article-title":"An extension strategy of Discovery Studio 2.0 for non-bonded interaction energy automatic calculation at the residue level","volume":"32","author":"Gao","year":"2011","journal-title":"Dong Wu Xue Yan Jiu Zool. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/bmb.20966","article-title":"Using the PyMOL application to reinforce visual understanding of protein structure","volume":"44","author":"Rigsby","year":"2016","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1021\/acschembio.0c00615","article-title":"A Small-Molecule Inhibitor to the Cytokine Interleukin-4","volume":"15","author":"Quinnell","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2119\/2007-00008.Villa","article-title":"The interleukin-8 (IL-8\/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats","volume":"13","author":"Villa","year":"2007","journal-title":"Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00249-011-0700-9","article-title":"Definition and testing of the GROMOS force-field versions 54A7 and 54B7","volume":"40","author":"Schmid","year":"2011","journal-title":"Eur. Biophys. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: A tool for high-throughput crystallography of protein-ligand complexes","volume":"60","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_26","unstructured":"Bekker, H., Berendsen, H., Dijkstra, E., Achterop, S., Vondrumen, R., Vanderspoel, D., Sijbers, A., Keegstra, H., and Renardus, M. (1992, January 24\u201328). Gromacs-A Parallel Computer for Molecular-Dynamics Simulations\u2014The University of Groningen research portalIn. Proceedings of the 4th International Conference on Computational Physics (PC 92), Prague, Czechoslovakia."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Soman, S.S., Sivakumar, K.C., and Sreekumar, E. (2010). Molecular dynamics simulation studies and in vitro site directed mutagenesis of avian beta-defensin Apl_AvBD2. BMC Bioinform., 11.","DOI":"10.1186\/1471-2105-11-S1-S7"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/14\/4555\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:52:26Z","timestamp":1760140346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/14\/4555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,17]]},"references-count":28,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["molecules27144555"],"URL":"https:\/\/doi.org\/10.3390\/molecules27144555","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,17]]}}}